Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Research area

Phase 1 Lymphoma trials

In lymphoma studies, researchers evaluate investigational medications and cell-based approaches for Hodgkin and non-Hodgkin lymphoma. If you are wondering whether a study may be a fit for you or for someone you care for, we at Phase 1 Cancer Trials can help you find out.

Updated

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Phase 1 lymphoma studies in numbers

Phase 1 lymphoma studies recruiting in the U.S.
283
states with a study site
48
studies that accept healthy volunteers
7

Source: ClinicalTrials.gov. Data processed .

Find Phase 1 lymphoma studies by state

These states have the most studies recruiting right now.

Phase 1 lymphoma studies recruiting now

As of November 17, 2026, 283 Phase 1 lymphoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.

What they test

  • medications232
  • biologics such as vaccines or antibodies86
  • procedures57
  • other approaches19
  • radiation15

A study can test more than one.

Main purpose

  • treating a condition269
  • diagnosis4
  • basic science3
  • other purposes2

Phase

  • Early Phase 112
  • Phase 1174
  • Phase 1/297

Who runs them

  • university, hospital or other160
  • industry105
  • government18

Who they enroll

  • adults (18 to 64)281
  • older adults (65 and over)244
  • children (under 18)68

7 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 283 studies.

Recently updated Phase 1 lymphoma studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Akron, OH · Albany, NY · Albuquerque, NM · and 129 more U.S. locations
    Registry record
    NCT04726241 · updated
  2. A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Debiopharm International SA
    Recruiting in
    Chicago, IL · Dallas, TX · Houston, TX · and 4 more U.S. locations
    Registry record
    NCT05765812 · updated
  3. Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

    • Early Phase 1
    • Ages 18 to 100
    • All sexes
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT07428707 · updated
  4. Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Abramson Cancer Center at Penn Medicine
    Recruiting in
    Philadelphia, PA · Salt Lake City, UT
    Registry record
    NCT07478848 · updated
  5. Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 1
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT07572136 · updated
  6. A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment

    • Phase 1
    • Ages 18 to 80
    • All sexes
    Sponsor
    Incyte Corporation
    Recruiting in
    Chandler, AZ · Orlando, FL · San Antonio, TX
    Registry record
    NCT07853040 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in the United States on ClinicalTrials.gov.

What lymphoma studies look at

Lymphoma studies test investigational medications and cell-based approaches for Hodgkin and non-Hodgkin lymphoma. No two of them ask the same things of you, or of the person you care for, because each is set up to answer a single, narrow question.

The word investigational applies to anything under test in a study. It tells you that how well the product works, and the risks it carries, are still being worked out by researchers. That is why the study is being run.

Who may be able to take part

Each study sets its own entry rules. Your age may count. So may your health history, the medications you take now, and the way a condition affects you. Some studies also enroll people without the condition.

Working out eligibility is not your job. A screening visit is where the study team makes that check. Our guide to eligibility and screening explains the process.

What taking part usually involves

  1. A first conversation

    The first conversation is with a coordinator. You hear a general outline of the study and can ask whatever you need to, and nothing further happens until that is done.

  2. Informed consent

    A written document from the study team sets out everything about the study, and the risks known so far are part of it. Whether you agree is your decision.

  3. Screening

    Screening is a set of health questions and tests. The results tell the study team whether a Phase 1 lymphoma trial is suitable in your case. Some people who go through screening do not move on to join.

  4. Study visits

    Joining a Phase 1 trial means coming to visits on a set schedule. Those visits let the team follow how you are doing over time. Leaving the study remains open to you at any point.

Questions about Phase 1 lymphoma studies

Do I need a diagnosis to join a study about lymphoma?

Each Phase 1 trial sets its own rule on this. A lymphoma diagnosis confirmed beforehand is a requirement for some, while for others the screening visit is where you are assessed. Which of the two applies to you is something the study team will tell you.

Would I have to change the care I receive now?

Whether your current care can continue depends on the study. Some Phase 1 lymphoma trials allow it and others do not. Please make no changes to your care by yourself. The study doctor goes through this with you, and before you decide, you are free to discuss it with your own doctor.

Is there a cost to take part?

There is generally no cost to participants. That covers study visits, study tests and the study medication. Our guide has the detail: read more about costs.

Ask about Phase 1 lymphoma studies

Send us a few details about yourself or the person you care for. A coordinator then gets in touch. An enquiry is only a question, and it leaves you under no obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call